Published in Gut on September 20, 2005
Vanilloid-induced conduction analgesia: selective, dose-dependent, long-lasting, with a low level of potential neurotoxicity. Anesth Analg (2008) 1.63
Calcium channel expression and applicability as targeted therapies in melanoma. Biomed Res Int (2015) 1.40
Animal models of cancer pain. Comp Med (2008) 1.35
Role of mitochondrial electron transport chain complexes in capsaicin mediated oxidative stress leading to apoptosis in pancreatic cancer cells. PLoS One (2011) 1.23
The role of Transient Receptor Potential Vanilloid 1 (TRPV1) channels in pancreatitis. Biochim Biophys Acta (2007) 1.14
Unraveling the mystery of pain in chronic pancreatitis. Nat Rev Gastroenterol Hepatol (2012) 1.11
Transient receptor potential channel TRPM8 is over-expressed and required for cellular proliferation in pancreatic adenocarcinoma. Cancer Lett (2010) 1.04
Pain and pain generation in pancreatic cancer. Langenbecks Arch Surg (2008) 0.94
Pain and chronic pancreatitis: a complex interplay of multiple mechanisms. World J Gastroenterol (2013) 0.93
Transient receptor potential type vanilloid 1 suppresses skin carcinogenesis. Cancer Res (2009) 0.93
Tumor tissue-derived formaldehyde and acidic microenvironment synergistically induce bone cancer pain. PLoS One (2010) 0.92
The cannabinoid receptor inverse agonist AM251 regulates the expression of the EGF receptor and its ligands via destabilization of oestrogen-related receptor α protein. Br J Pharmacol (2011) 0.87
Involvement of Transient Receptor Potential Melastatin 7 Channels in Sophorae Radix-induced Apoptosis in Cancer Cells: Sophorae Radix and TRPM7. J Pharmacopuncture (2012) 0.87
Vanilloids induce oral cancer apoptosis independent of TRPV1. Oral Oncol (2014) 0.84
Responses of human adipose-derived mesenchymal stem cells to chemical microenvironment of the intervertebral disc. J Transl Med (2012) 0.84
Polymorphisms in gene encoding TRPV1-receptor involved in pain perception are unrelated to chronic pancreatitis. BMC Gastroenterol (2009) 0.80
hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma. Br J Cancer (2015) 0.80
Pain management in pancreatic cancer. Cancers (Basel) (2010) 0.80
Wittig derivatization of sesquiterpenoid polygodial leads to cytostatic agents with activity against drug resistant cancer cells and capable of pyrrolylation of primary amines. Eur J Med Chem (2015) 0.79
Involvement of endoplasmic reticulum stress in capsaicin-induced apoptosis of human pancreatic cancer cells. Evid Based Complement Alternat Med (2013) 0.77
Involvement of the phosphoinositide 3-kinase/Akt pathway in apoptosis induced by capsaicin in the human pancreatic cancer cell line PANC-1. Oncol Lett (2012) 0.77
Synthetic and Biological Studies of Sesquiterpene Polygodial: Activity of 9-Epipolygodial against Drug-Resistant Cancer Cells. ChemMedChem (2015) 0.76
Current understanding of the neuropathophysiology of pain in chronic pancreatitis. World J Gastrointest Pathophysiol (2015) 0.75
Haemorrhoids and transient receptor potential vanilloid 1. Gut (2006) 0.75
Road map for pain management in pancreatic cancer: A review. World J Gastrointest Oncol (2016) 0.75
Post-transcriptional regulation of 5'-untranslated regions of human Transient Receptor Potential Vanilloid type-1 (TRPV-1) channels: role in the survival of glioma patients. Oncotarget (2016) 0.75
Pain in Patients with Pancreatic Cancer: Prevalence, Mechanisms, Management and Future Developments. Dig Dis Sci (2017) 0.75
The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature (1997) 30.59
Cancer statistics, 2004. CA Cancer J Clin (2004) 15.72
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med (2004) 13.34
Pain and its treatment in outpatients with metastatic cancer. N Engl J Med (1994) 9.54
Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol Rev (1999) 7.20
Management of pain in elderly patients with cancer. SAGE Study Group. Systematic Assessment of Geriatric Drug Use via Epidemiology. JAMA (1998) 6.88
Symptoms and suffering at the end of life in children with cancer. N Engl J Med (2000) 6.75
Pharmacologically induced selective degeneration of chemosensitive primary sensory neurones. Nature (1978) 3.77
Acid potentiation of the capsaicin receptor determined by a key extracellular site. Proc Natl Acad Sci U S A (2000) 3.55
Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol (1997) 2.75
The biochemistry of programmed cell death. FASEB J (1995) 2.63
Capsaicin binds to the intracellular domain of the capsaicin-activated ion channel. J Neurosci (1999) 2.29
Deletion of vanilloid receptor 1-expressing primary afferent neurons for pain control. J Clin Invest (2004) 2.28
The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer. J Clin Invest (1998) 2.22
Capsaicin-induced ion fluxes in dorsal root ganglion cells in culture. J Neurosci (1988) 2.18
Mitochondrion as a novel target of anticancer chemotherapy. J Natl Cancer Inst (2000) 1.95
Three classes of inhibitors share a common binding domain in mitochondrial complex I (NADH:ubiquinone oxidoreductase). J Biol Chem (1999) 1.81
Vanilloid receptor 1 immunoreactivity in inflamed human bowel. Lancet (2001) 1.79
Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group Study. J Clin Oncol (1998) 1.72
Examining the role of mitochondrial respiration in vanilloid-induced apoptosis. J Natl Cancer Inst (2002) 1.71
Loss of BNIP3 expression is a late event in pancreatic cancer contributing to chemoresistance and worsened prognosis. Oncogene (2005) 1.67
Ligand-induced dynamic membrane changes and cell deletion conferred by vanilloid receptor 1. J Biol Chem (2000) 1.59
Resistance of pancreatic cancer to gemcitabine treatment is dependent on mitochondria-mediated apoptosis. Int J Cancer (2004) 1.43
Adjuvant therapy in pancreatic cancer: historical and current perspectives. Ann Oncol (2003) 1.42
Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion. Cancer Res (1997) 1.41
Tumor necrosis factor enhances the capsaicin sensitivity of rat sensory neurons. J Neurosci (1997) 1.40
Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, double-blind, placebo controlled trial. J Urol (2005) 1.35
Induction of apoptosis in HL-60 cells by pungent vanilloids, [6]-gingerol and [6]-paradol. Cancer Lett (1998) 1.24
The role of endogenous nerve growth factor in human diabetic neuropathy. Nat Med (1996) 1.19
Agonist recognition sites in the cytosolic tails of vanilloid receptor 1. J Biol Chem (2002) 1.14
Cellular mechanism of action of resiniferatoxin: a potent sensory neuron excitotoxin. Brain Res (1990) 1.12
RUNX3 expression in primary and metastatic pancreatic cancer. J Clin Pathol (2004) 1.11
Capsaicin-induced apoptosis in SK-Hep-1 hepatocarcinoma cells involves Bcl-2 downregulation and caspase-3 activation. Cancer Lett (2001) 1.10
Capsaicin inhibits preferentially the NADH oxidase and growth of transformed cells in culture. Proc Natl Acad Sci U S A (1995) 1.09
Inhibitory effect of dietary curcumin on skin carcinogenesis in mice. Cancer Lett (1997) 1.09
Modifying effects of dietary capsaicin and rotenone on 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis. Carcinogenesis (2002) 1.05
Capsaicin-induced neurotoxicity in cultured dorsal root ganglion neurons: involvement of calcium-activated proteases. Neuroscience (1995) 1.03
Mitochondrial respiration is uniquely associated with the prooxidant and apoptotic effects of N-(4-hydroxyphenyl)retinamide. J Biol Chem (2001) 1.02
Selective induction of apoptosis by capsaicin in transformed cells: the role of reactive oxygen species and calcium. Cell Death Differ (1999) 1.00
Gefitinib ('Iressa', ZD1839), a selective epidermal growth factor receptor tyrosine kinase inhibitor, inhibits pancreatic cancer cell growth, invasion, and colony formation. Int J Oncol (2004) 0.98
Inhibition by capsaicin of NADH-quinone oxidoreductases is correlated with the presence of energy-coupling site 1 in various organisms. Arch Biochem Biophys (1990) 0.97
Induction of apoptosis by capsaicin in A172 human glioblastoma cells. Cancer Lett (2000) 0.93
Capsaicin can alter the expression of tumor forming-related genes which might be followed by induction of apoptosis of a Korean stomach cancer cell line, SNU-1. Cancer Lett (1997) 0.91
Capsaicin and its analogs inhibit the activity of NADH-coenzyme Q oxidoreductase of the mitochondrial respiratory chain. Arch Biochem Biophys (1989) 0.90
Apoptosis induced by inhibitors of the plasma membrane NADH-oxidase involves Bcl-2 and calcineurin. Cell Growth Differ (1996) 0.90
Probing the molecular program of apoptosis by cancer chemopreventive agents. J Cell Biochem Suppl (1995) 0.89
Inhibitory effects of topical application of low doses of curcumin on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion and oxidized DNA bases in mouse epidermis. Carcinogenesis (1997) 0.89
Chemoprotective effects of capsaicin and diallyl sulfide against mutagenesis or tumorigenesis by vinyl carbamate and N-nitrosodimethylamine. Carcinogenesis (1995) 0.87
The roles of thymidylate synthase and p53 in regulating Fas-mediated apoptosis in response to antimetabolites. Clin Cancer Res (2004) 0.86
Neonatal primary neuronal death induced by capsaicin and axotomy involves an apoptotic mechanism. Brain Res (1998) 0.86
Capsaicin-induced depolarisation of mitochondria in dorsal root ganglion neurons is enhanced by vanilloid receptors. Neuroscience (2001) 0.85
Effects of capsaicin on chemically-induced two-stage mouse skin carcinogenesis. Cancer Lett (1997) 0.85
Capsaicin inhibits plasma membrane NADH oxidase and growth of human and mouse melanoma lines. Eur J Cancer (1996) 0.85
Induction of apoptosis by vanilloid compounds does not require de novo gene transcription and activator protein 1 activity. Cell Growth Differ (1998) 0.84
Colorectal cancer chemoprevention: biochemical targets and clinical development of promising agents. Eur J Cancer (2001) 0.82
Electron microscopic demonstration of nick end-labeled DNA fragments during capsaicin-induced apoptosis of trigeminal primary neurons in neonatal rats. Brain Res (1999) 0.81
Preoperative versus postoperative chemoradiation for patients with resected pancreatic adenocarcinoma. Am Surg (1998) 0.81
Cell death of primary afferent nerve cells in neonatal mice treated with capsaicin. Anat Sci Int (2002) 0.80
Impairment of rat thymocyte differentiation and functions by neonatal capsaicin treatment is associated with induction of apoptosis. J Neuroimmunol (2000) 0.79
Phorboid 20-homovanillates induce apoptosis through a VR1-independent mechanism. Chem Biol (2000) 0.79
Inhibitory effect of capsaicin on mouse lung tumor development. In Vivo (1992) 0.79
Mechanism of the inhibitory action of capsaicin on energy metabolism by rat liver mitochondria. Biochem Pharmacol (1981) 0.76
Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet (2001) 5.75
Expression of crumbs confers apical character on plasma membrane domains of ectodermal epithelia of Drosophila. Cell (1995) 4.10
Randomized clinical trial on the effect of coffee on postoperative ileus following elective colectomy. Br J Surg (2012) 4.01
Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg (2004) 3.90
Immunolocalization of sarcolemmal dihydropyridine receptor and sarcoplasmic reticular triadin and ryanodine receptor in rabbit ventricle and atrium. J Cell Biol (1995) 3.28
Fewer adhesions induced by laparoscopic surgery? Surg Endosc (2004) 3.11
Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg (2001) 2.94
IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells. J Immunol (2000) 2.93
Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells. Pancreas (2004) 2.85
Acute necrotizing pancreatitis: treatment strategy according to the status of infection. Ann Surg (2000) 2.73
Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein. Oncogene (1997) 2.58
Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha. J Clin Invest (1992) 2.54
Pancreatic fistula after pancreatic head resection. Br J Surg (2000) 2.44
Use of accurate diagnostic criteria may increase incidence of stercoral perforation of the colon. Dis Colon Rectum (2000) 2.41
Role of octreotide in the prevention of postoperative complications following pancreatic resection. Am J Surg (1992) 2.38
Incisional hernia rate 3 years after midline laparotomy. Br J Surg (2013) 2.37
Sulforaphane targets pancreatic tumour-initiating cells by NF-kappaB-induced antiapoptotic signalling. Gut (2008) 2.36
Randomized controlled multicentre study of the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitis. Br J Surg (1995) 2.36
Molecular characterisation of pancreatic ductal adenocarcinoma in patients under 40. J Clin Pathol (2006) 2.33
Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer. Br J Cancer (2005) 2.32
Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance. Clin Cancer Res (2001) 2.24
The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer. J Clin Invest (1998) 2.22
Systematic review and meta-analysis of technique for closure of the pancreatic remnant after distal pancreatectomy. Br J Surg (2005) 2.18
PDGF-D, a new protease-activated growth factor. Nat Cell Biol (2001) 2.17
Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness. Anticancer Res (1993) 2.15
Retroperitoneal endoscopic neurectomy for nerve entrapment after hernia repair. Br J Surg (1997) 2.12
Missed diaphragmatic injuries and their long-term sequelae. J Trauma (1998) 2.09
Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency. Digestion (2000) 2.09
The problem of the poor control arm in surgical randomized controlled trials. Br J Surg (2012) 2.08
Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage. Cancer Res (1993) 2.08
Management of complications after pancreaticoduodenectomy in a high volume centre: results on 150 consecutive patients. Dig Surg (2001) 2.08
Incidence, risk factors, and prevention of biliary tract injuries during laparoscopic cholecystectomy in Switzerland. World J Surg (2001) 2.07
Circulatory and respiratory complications of carbon dioxide insufflation. Dig Surg (2004) 2.06
Overexpression of HER2/neu oncogene in human pancreatic carcinoma. Hum Pathol (1993) 2.05
Neuroimmune appendicitis. Lancet (1999) 2.05
Management of acute pancreatitis: from surgery to interventional intensive care. Gut (2005) 2.02
[The diagnostic value of the amino acid absorption test in detection of a disorder of exocrine pancreatic function]. Z Gastroenterol (1992) 2.02
Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. EORTC Study Group on Quality of Life. Eur J Cancer (1999) 1.99
Carcinoid of the ampulla of Vater. Clinical characteristics and morphologic features. Cancer (1994) 1.97
Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis. Gastroenterology (2001) 1.97
Late mortality in patients with severe acute pancreatitis. Br J Surg (2001) 1.92
Systematic review and meta-analysis of standard and extended lymphadenectomy in pancreaticoduodenectomy for pancreatic cancer. Br J Surg (2007) 1.92
High coincidence of Mirizzi syndrome and gallbladder carcinoma. Surgery (1997) 1.89
Effect of preoperative biliary drainage on surgical outcome after pancreatoduodenectomy. Am J Surg (2001) 1.87
Robot-assisted abdominal surgery. Br J Surg (2004) 1.85
Collaborative annotation of genes and proteins between UniProtKB/Swiss-Prot and dictyBase. Database (Oxford) (2009) 1.85
VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma. Br J Cancer (2008) 1.84
Meta-analysis of neoadjuvant treatment modalities and definitive non-surgical therapy for oesophageal squamous cell cancer. Br J Surg (2011) 1.82
Detection and localization of Mip-3alpha/LARC/Exodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer. Int J Cancer (1999) 1.81
ESPEN guidelines on nutrition in acute pancreatitis. European Society of Parenteral and Enteral Nutrition. Clin Nutr (2002) 1.75
Robot-assisted versus conventional laparoscopic fundoplication: short-term outcome of a pilot randomized controlled trial. Surg Endosc (2007) 1.75
Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression. Clin Cancer Res (1997) 1.74
Role of serum carbohydrate antigen 19-9 and carcinoembryonic antigen in distinguishing between benign and invasive intraductal papillary mucinous neoplasm of the pancreas. Br J Surg (2010) 1.73
Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials. Br J Cancer (2009) 1.69
Heparanase expression in primary and metastatic pancreatic cancer. Cancer Res (2001) 1.67
Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer. Int J Cancer (1995) 1.67
The role of infection in acute pancreatitis. Gut (1999) 1.66
Imprinting of IGF2 P0 transcript and novel alternatively spliced INS-IGF2 isoforms show differences between mouse and human. Hum Mol Genet (2006) 1.63
The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer. Oncogene (1999) 1.63
Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma: a retrospective analysis. Ann Surg (1998) 1.61
Laparoscopic restorative proctocolectomy. Br J Surg (2005) 1.60
Microarray-based identification of differentially expressed growth- and metastasis-associated genes in pancreatic cancer. Cell Mol Life Sci (2003) 1.60
KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases. Cancer Res (1996) 1.59
Clinical significance of liver ischaemia after pancreatic resection. Br J Surg (2011) 1.59
The suprapubic approach for laparoscopic appendectomy. Surg Endosc (2001) 1.56
Overexpression and activation of the tyrosine kinase Src in human pancreatic carcinoma. Biochem Biophys Res Commun (1998) 1.52
Randomized trial of duodenum-preserving pancreatic head resection versus pylorus-preserving Whipple in chronic pancreatitis. Am J Surg (1995) 1.52
High prevalence of Mycobacterium avium subspecies paratuberculosis IS900 DNA in gut tissues from individuals with Crohn's disease. Gut (2005) 1.51
Endoscopic retroperitoneal neurectomy for chronic pain after groin surgery. Br J Surg (2009) 1.50
A pancreatic cancer-specific expression profile. Oncogene (1996) 1.50
Randomized clinical trial of stapler versus clamp-crushing transection in elective liver resection. Br J Surg (2014) 1.50